IPO registrations (S-1, F-1) · Registrants
Aclarion, Inc.
- SEC CIK
- 1635077 · filings on EDGAR ↗
- Former names
- Nocimed, Inc. (2015–2021)
- Registration
- Form S-1, first filed 2022-01-06, last 2025-01-10; 7 initial registrations, 13 amendments
- Outcome
- Final prospectus filed 2022-04-25; declared effective 2022-04-21
- Industry (SIC)
- Services-Medical Laboratories 8071
- Incorporated in
- DE
- Business address
- 8181 ARISTA PLACE, STE 100, Broomfield, CO 80021
- EIN
- 47-3324725
- Ticker
- ACON, ACONW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Aclarion, Inc. on the corporate pages
Offering terms
- Proposed price range
- $4.50–$6.50 per share (S-1/A filed 2022-04-20)
- Final price
- $4.35 per share, below the range (424B4 filed 2022-04-25, an initial public offering)
- Shares sold
- 2,165,000
- Gross proceeds
- $9,417,750 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ACON
- Lead underwriters
- Maxim Group (2,165,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Aclarion, Inc. Fuzzy (name and state)
- Business registration: ACLARION INC Fuzzy (name and state)
- Form D issuer: Aclarion, Inc. EXACT (CIK (EXACT))
- SEC filer: Aclarion, Inc. EXACT (CIK (EXACT))
Filings 35
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-01-06 | S-1 | S-1 (registration) | Aclarion, Inc. | 0001683168-22-000097 ↗ |
| 2022-03-04 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-22-001434 ↗ |
| 2022-03-23 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-22-001851 ↗ |
| 2022-04-01 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-22-002267 ↗ |
| 2022-04-19 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-22-002795 ↗ |
| 2022-04-20 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-22-002814 ↗ |
| 2022-04-21 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-22-001046 ↗ |
| 2022-04-25 | 424B4 | 424B4 (final prospectus) | Aclarion, Inc. | 0001683168-22-002903 ↗ |
| 2023-07-03 | S-1 | S-1 (registration) | Aclarion, Inc. | 0001683168-23-004614 ↗ |
| 2023-07-12 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-23-004813 ↗ |
| 2023-07-14 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-23-002098 ↗ |
| 2023-10-10 | S-1 | S-1 (registration) | Aclarion, Inc. | 0001683168-23-007031 ↗ |
| 2023-10-20 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-23-007308 ↗ |
| 2023-10-20 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-23-003043 ↗ |
| 2023-12-11 | S-1 | S-1 (registration) | Aclarion, Inc. | 0001683168-23-008784 ↗ |
| 2024-01-22 | S-1 | S-1 (registration) | Aclarion, Inc. | 0001683168-24-000371 ↗ |
| 2024-01-31 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-24-000585 ↗ |
| 2024-02-01 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-24-000288 ↗ |
| 2024-02-06 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-24-000730 ↗ |
| 2024-02-21 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-24-001095 ↗ |
| 2024-02-23 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-24-001147 ↗ |
| 2024-02-26 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-24-000543 ↗ |
| 2024-02-27 | 424B4 | 424B4 (final prospectus) | Aclarion, Inc. | 0001683168-24-001189 ↗ |
| 2024-09-23 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-24-002931 ↗ |
| 2024-10-24 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-24-003260 ↗ |
| 2024-10-25 | S-1 | S-1 (registration) | Aclarion, Inc. | 0001683168-24-007397 ↗ |
| 2024-11-04 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-24-003369 ↗ |
| 2024-11-08 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-24-003437 ↗ |
| 2024-12-11 | S-1 | S-1 (registration) | Aclarion, Inc. | 0001683168-24-008624 ↗ |
| 2024-12-26 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-24-008988 ↗ |
| 2025-01-10 | S-1/A | S-1/A (amendment) | Aclarion, Inc. | 0001683168-25-000233 ↗ |
| 2025-01-14 | S-1MEF | S-1MEF (added securities) | Aclarion, Inc. | 0001683168-25-000349 ↗ |
| 2025-01-14 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-25-000103 ↗ |
| 2025-01-16 | 424B4 | 424B4 (final prospectus) | Aclarion, Inc. | 0001683168-25-000389 ↗ |
| 2025-05-05 | EFFECT | EFFECT (declared effective) | Aclarion, Inc. | 9999999995-25-001425 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-20 | S-1/A | registration statement | $4.50–$6.50 | $5.50 | 2,000,000 | $11,000,000 | Nasdaq ACON | 1 | primary document; range, price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
| 2022-04-25 | 424B4 | final prospectus | $4.35 | 2,165,000 | $9,417,750 | Nasdaq ACON | 1 | primary document; price line, shares headline, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Breidbart Scott | Director | 4 | 2022–2026 | ||
| Deitsch Stephen | Director | 3 | 2022–2026 | ||
| Neal David K | Director | 7 | 2022–2026 | ||
| Ness Brent | Director,Officer | Chief Executive Officer | 8 | 2022–2026 | |
| Sequira Amanda Mae | Director | 4 | 2022–2026 | ||
| Thramann Jeffrey John | Director,Officer; Officer | Executive Chairman | 5 | 2022–2026 | |
| Wesemann William | Director | 7 | 2022–2026 | ||
| Bond Ryan | Director; Officer | Chief Strategy Officer | 4 | 2022–2026 | |
| DIRKS MICHAEL W | Other; TenPercentOwner | 3 | 2022 | ||
| Lorbiecki John Paul | Officer | Chief Financial Officer | 3 | 2022 | |
| NUVASIVE INC | TenPercentOwner | 2 | 2022 | ||
| SC Capital 1 LLC | Other; TenPercentOwner | 3 | 2022 | ||
| Gould Gregory A | Officer | CFO; Chief Financial Officer | 4 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-10-15 | Aclarion, Inc. | Other | $1,000,000 | $1,000,000 | 3 | 1 |
| 2023-05-31 | Aclarion, Inc. | Other | $2,000,000 | $2,000,000 | 2 | 1 |
| 2021-10-26 | Nocimed, Inc. | Other | $2,000,000 | $2,000,000 | 4 | 1 |
| 2020-03-12 | Nocimed, Inc. | Other | $2,500,000 | $1,402,965 | 12 | 1 |
| 2017-08-11 | Nocimed, Inc. | Other Health Care | $4,000,000 | $3,258,099 | 14 | 2 |
| 2015-03-03 | Nocimed, Inc. | Other Health Care | $5,000,000 | $2,023,736 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Aclarion, Inc. | CO | State business registries | name and state |
| Business registration | ACLARION INC | CO | State business registries | name and state |
| Form D issuer | Aclarion, Inc. | CO | Form D private offerings | CIK (EXACT) |
| SEC filer | Aclarion, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Medical Laboratories, CO first:
- BIODESIX INC CO
- CannLabs, Inc. CO
- Centogene N.V. 2M
- Med BioGene Inc. A1
- DYNACARE INC A6
- GenEmbryomics Ltd C3
- MDxHealth SA C9
- INSIGHT HEALTH SERVICES CORP CA
- CLARIENT, INC CA
- BIOCEPT INC CA
In other datasets, the same topic (Health) in CO:
- Nonprofit: 3 4 FIGHTING PARKINSONS (Nonprofits (IRS Form 990))
Interests: Services-Medical Laboratories · Health